GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioservo Technologies AB (OSTO:BIOS) » Definitions » Total Equity

Bioservo Technologies AB (OSTO:BIOS) Total Equity : kr38.53 Mil (As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Bioservo Technologies AB Total Equity?

Bioservo Technologies AB's total equity for the quarter that ended in Sep. 2023 was kr38.53 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Bioservo Technologies AB Total Equity Historical Data

The historical data trend for Bioservo Technologies AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioservo Technologies AB Total Equity Chart

Bioservo Technologies AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Equity
Get a 7-Day Free Trial 40.14 75.26 62.31 62.77 37.46

Bioservo Technologies AB Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.46 37.46 28.05 48.29 38.53

Bioservo Technologies AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Bioservo Technologies AB's Total Equity for the fiscal year that ended in Dec. 2022 is calculated as

Total Equity=Total Assets(Q: Dec. 2022 )-Total Liabilities(Q: Dec. 2022 )
=52.537-15.074
=37.46

Bioservo Technologies AB's Total Equity for the quarter that ended in Sep. 2023 is calculated as

Total Equity=Total Assets(Q: Sep. 2023 )-Total Liabilities(Q: Sep. 2023 )
=49.739-11.21
=38.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioservo Technologies AB Total Equity Related Terms

Thank you for viewing the detailed overview of Bioservo Technologies AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioservo Technologies AB (OSTO:BIOS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioservo Technologies AB (OSTO:BIOS) » Definitions » Total Equity
Comparable Companies
XSAT:MEDIMI XSAT:ODIN XSAT:AUDNTS OSTO:S2M XSAT:EURI B XSAT:BIBB NGM:PRLD OSTO:IZAFE B OSTO:ORTI A ISRG XPAR:EL BDX XSWX:ALC TSE:7741 WST OCSE:COLO B RMD TSE:4543 XSWX:STMN BAX
Traded in Other Exchanges
N/A
Address
Torshamnsgatan 35, Kista, SWE, 164 40
Website
https://www.bioservo.com
Bioservo Technologies AB is a Sweden based wearable muscle strengthening systems provider company. It develops wearable technologies based on bionic soft robotics. The company offers SEM Gloves, a grip strengthening aid designed for people with impaired hand function or grip-intensive occupations.